The expression of angiotensin-converting enzyme 2 (ACE2) is substantially increased in patients with T2DM, and this receptor has been found to be a molecular target used by SARS-CoV-2 to infect human cells [8]. The gene discussed is ACE2; the disease is type 2 diabetes mellitus.